31 results
Page 2 of 2
6-K
EX-10.1
8nte 6d310sm
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
o4rfmpzpzw12b
11 May 20
Prospectus supplement for primary offering
9:23am
424B5
8c6m16r
17 May 19
Prospectus supplement for primary offering
5:19pm
424B5
6mn14f8
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-1.1
ux4382s3
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
424B4
bxka0tfc8 abej
2 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
etaiophgb
1 Aug 14
Prospectus supplement with pricing info
12:00am
F-1/A
EX-10.11
njsv bpa7ibt7
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.5
lchrp p6k8i1b89bm
18 Jul 14
Registration statement (foreign) (amended)
12:00am